BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12927313)

  • 1. Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy.
    Palomba S; Di Carlo C; Morelli M; Russo T; Noia R; Nappi C; Mastrantonio P; Zullo F
    Maturitas; 2003 Aug; 45(4):267-73. PubMed ID: 12927313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P
    Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
    Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
    Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: a prospective study.
    Christodoulakos GE; Lambrinoudaki IV; Vourtsi AD; Panoulis KP; Kelekis DA; Creatsas GC
    Menopause; 2002; 9(2):110-6. PubMed ID: 11875329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
    Lundström E; Hirschberg AL; Söderqvist G
    Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
    Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tibolone on sexual function in late postmenopausal women.
    Kamenov ZA; Todorova MK; Christov VG
    Folia Med (Plovdiv); 2007; 49(1-2):41-8. PubMed ID: 18018469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
    Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
    Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormone therapy and mammographic breast density.
    Marchesoni D; Driul L; Ianni A; Fabiani G; Della Martina M; Zuiani C; Bazzocchi M
    Maturitas; 2006 Jan; 53(1):59-64. PubMed ID: 15939560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tibolone on the breast of postmenopausal women.
    Wang PH; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V; Perreault S; Lachaine J
    Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
    Lundström E; Christow A; Kersemaekers W; Svane G; Azavedo E; Söderqvist G; Mol-Arts M; Barkfeldt J; von Schoultz B
    Am J Obstet Gynecol; 2002 Apr; 186(4):717-22. PubMed ID: 11967497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of mammographic density and (99m)Tc-sestamibi scintimammographic uptake in postmenopausal women on hormone replacement therapy.
    Nahas-Neto J; Luca LA; Griva BL; Morceli J; Nahas EA; Moriguchi SM; Uemura G; Traiman P
    Maturitas; 2006 Jan; 53(1):97-106. PubMed ID: 15941630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tibolone: the way to beat many a postmenopausal ailments.
    Lazovic G; Radivojevic U; Marinkovic J
    Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women.
    Egarter C; Topcuoglu A; Vogl S; Sator M
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):649-53. PubMed ID: 12190840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.